Journal Information

Statistics

Follow this link to access the full text of the article

Scientific Letter
Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis
El osimertinib como tratamiento del adenocarcinoma de pulmón con mutación positiva del EGFR complicado con dermatomiositis
Masahiro Yamasakia,
Corresponding author
myamasanjp@yahoo.co.jp

Corresponding author.
, Naoko Matsumotoa, Shota Nakanob, Kazuma Kawamotoa, Masaya Taniwakia, Yusuke Izumia, Masaya Otoharaa, Shinji Nabeshimac, Nobuyuki Ohashid, Noboru Hattoric
a Department of Respiratory Disease, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
b Department of Rheumatology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
c Department of Molecular and Internal Medicine, Institute of Biomedical & Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan
d Ohashi Clinic, Naka-ku, Hiroshima, Japan
Read
2599
Times
was read the article
831
Total PDF
1768
Total HTML
Share statistics
Article information
ISSN: 03002896
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 64 30 94
2024 October 80 35 115
2024 September 84 30 114
2024 August 102 52 154
2024 July 83 25 108
2024 June 102 33 135
2024 May 112 37 149
2024 April 76 31 107
2024 March 60 34 94
2024 February 45 29 74
2023 March 15 4 19
2023 February 70 24 94
2023 January 55 41 96
2022 December 95 33 128
2022 November 98 27 125
2022 October 105 38 143
2022 September 81 25 106
2022 August 70 42 112
2022 July 56 52 108
2022 June 49 44 93
2022 May 53 34 87
2022 April 87 36 123
2022 March 66 34 100
2022 February 27 25 52
2021 December 2 0 2
2021 June 0 2 2
2021 February 1 0 1
2021 January 8 8 16
2020 December 12 12 24
2020 September 2 2 4
2020 August 8 12 20
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?